The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
Public ClinicalTrials.gov record NCT02793128. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of UGN-101 on Ablation of Upper Urinary Tract Urothelial Carcinoma
Study identification
- NCT ID
- NCT02793128
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- UroGen Pharma Ltd.
- Industry
- Enrollment
- 71 participants
Conditions and interventions
Interventions
- UGN-101 instillations Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 3, 2017
- Primary completion
- Apr 4, 2019
- Completion
- Mar 4, 2020
- Last update posted
- Dec 21, 2020
2017 – 2020
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Hospital | Phoenix | Arizona | 85054 | — |
| Loma Linda Cancer Center | Loma Linda | California | 92354 | — |
| University of California | Los Angeles | California | 90095 | — |
| Providence Medical Institute | Santa Monica | California | 90404 | — |
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | — |
| Loyola University Medical Center, Department of Urology | Maywood | Illinois | 60153 | — |
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | — |
| John Hopkins University | Baltimore | Maryland | 21218 | — |
| University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Mayo Clinic health system | Rochester | Minnesota | 55905 | — |
| Urology Center Las Vegas | Las Vegas | Nevada | 89144 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Weill Cornell Medical Center | New York | New York | 10065 | — |
| Montefiore Medical Center (Albert Einstein) | The Bronx | New York | 10467 | — |
| University of north carolina - chapel hill | Chapel Hill | North Carolina | 27514 | — |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Penn State College of Medicine | Hershey | Pennsylvania | 17033 | — |
| Thomas Jefferson University Hospitals | Philadelphia | Pennsylvania | 19107 | — |
| MD Anderson | Houston | Texas | 77006 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Seattle Cancer Care Alliance (University of Washington) | Seattle | Washington | 98109--1023 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02793128, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2020 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02793128 live on ClinicalTrials.gov.